Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HABA LABORATORIESTSE:4925 -0.28%67 ROC (Joel Greenblatt) % is 23.48% as of Mar. 2026, which is 71% above its 10-year median of 13.73. GuruFocus rates TSE:4925 with a GF Score™ of 67/100 and a GF Value™ of 円1,855.39 (Fairly Valued). The stock has 2 warning signs investors should review. Among 1,981 Consumer Packaged Goods companies, HABA LABORATORIES ranks better than 61.03% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. HABA LABORATORIES's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 23.48%.
The historical rank and industry rank for HABA LABORATORIES's ROC (Joel Greenblatt) % or its related term are showing as below:
TSE:4925'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -26.58 Med: 13.73 Max: 46.15
Current: 16.23
During the past 13 years, HABA LABORATORIES's highest ROC (Joel Greenblatt) % was 46.15%. The lowest was -26.58%. And the median was 13.73%.
TSE:4925's ROC (Joel Greenblatt) % is ranked better than 61.03% of 1981
companies
in the Consumer Packaged Goods industry
Industry Median: 11.99
vs TSE:4925: 16.23
HABA LABORATORIES's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
HABA LABORATORIES ROC (Joel Greenblatt) % Related Terms
HABA LABORATORIES ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for HABA LABORATORIES's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4925 vs PG, CL, KVUE: ROC (Joel Greenblatt) % Comparison
For the Household & Personal Products subindustry, HABA LABORATORIES's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HABA LABORATORIES ROC (Joel Greenblatt) % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, HABA LABORATORIES's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where HABA LABORATORIES's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 23.48% mean?
HABA LABORATORIES (TSE:4925) has a ROC (Joel Greenblatt) % of 23.48% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on HABA LABORATORIES and its competitors. This is 71% above median its historical median of 13.73. According to the industry distribution chart, HABA LABORATORIES ranks #772 out of 1981 companies in the Consumer Packaged Goods industry, placing it in the top 39%.
Is HABA LABORATORIES's ROC (Joel Greenblatt) % too high?
HABA LABORATORIES's current ROC (Joel Greenblatt) % of 23.48% is 71% above median its 10-year median of 13.73. The Consumer Packaged Goods industry median ROC (Joel Greenblatt) % is 11.99. HABA LABORATORIES's value of 23.48% is 95.8% above this industry median. Based on the distribution chart, HABA LABORATORIES ranks #772 out of 1981 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, HABA LABORATORIES has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does HABA LABORATORIES's ROC (Joel Greenblatt) % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, HABA LABORATORIES ranks #772 out of 1981 companies for ROC (Joel Greenblatt) %. This puts HABA LABORATORIES in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 11.99. HABA LABORATORIES's value of 23.48% is 95.8% above this benchmark. While the company's 10-year median is 13.73 vs. the industry median of 11.99, HABA LABORATORIES has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Consumer Packaged Goods company?
The median ROC (Joel Greenblatt) % among Consumer Packaged Goods companies is 11.99, based on 1,981 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HABA LABORATORIES's current ROC (Joel Greenblatt) % of 23.48% is 95.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on HABA LABORATORIES and its competitors. For the Consumer Packaged Goods industry, the median ROC (Joel Greenblatt) % is 11.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HABA LABORATORIES's current ROC (Joel Greenblatt) % is 23.48%, which is 71% above median its own 10-year median of 13.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HABA LABORATORIES stock overvalued right now?
Based on GuruFocus' analysis, HABA LABORATORIES (TSE:4925) is currently considered Fairly Valued. The stock's GF Value™ is 円1,855.39, compared to a current price of 円1,755.00 — trading 5.4% below its estimated fair value. The current ROC (Joel Greenblatt) % is 23.48%, which is 71% above median its 10-year median of 13.73 and 95.8% above the Consumer Packaged Goods industry median of 11.99. HABA LABORATORIES's overall GF Score™ is 67/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For HABA LABORATORIES (TSE:4925), the current ROC (Joel Greenblatt) % is 23.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HABA LABORATORIES (TSE:4925) Overvalued in 2026?
Based on GuruFocus' analysis, HABA LABORATORIES stock appears to be undervalued.
The current stock price of 円1,755.00 is trading 5.4% below its estimated GF Value™ of 円1,855.39.
GuruFocus considers HABA LABORATORIES to be Fairly Valued.
Key valuation signals for TSE:4925:
ROC (Joel Greenblatt) %: 23.48% (71% above median its 10-year median of 13.73)
GF Value™: 円1,855.39 vs. price of 円1,755.00 (5.4% below fair value)
Industry Position: 95.8% above the Consumer Packaged Goods median (#772 of 1981)
No single metric tells the full story. See the TSE:4925 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HABA LABORATORIES Inc along with its subsidiaries develops, manufactures and distributes natural cosmetics, quasi-drugs and nutritional supplements. The company sells its products through shops, delivery centers, mail order, and the Internet.
67GF Score
Get the complete analysis for TSE:4925
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4925 has been successfully added to your 
